バイオサージェリー市場：製品、供給源、用途、エンドユーザー別-2025-2030年世界予測

バイオサージェリー市場は、2023年に151億3,000万米ドルと評価され、2024年には163億5,000万米ドルに達すると予測され、CAGR 8.17％で成長し、2030年には262億2,000万米ドルに達すると予測されています。

バイオサージェリー市場は、止血、密封、組織修復を助ける生物学的由来の外科用製品の開発と応用に焦点を当てています。この分野は、手術結果の向上、手術リスクの軽減、回復の促進に不可欠です。高齢化、外科手術の増加、技術の進歩に牽引され、同市場は成長態勢にあるが、高コストや厳しい規制の監視といった課題に直面しています。バイオサージェリーは、整形外科、心臓血管外科、神経外科などさまざまな手術に応用されており、エンドユーザーは病院、診療所、外来手術センターです。成長の主因は、低侵襲手術への注目の高まり、新興市場での拡大、世界のヘルスケアインフラの改善です。ビジネスチャンスは、生体適合材料や再生医療の進歩を反映した、費用対効果が高く効果的な次世代製品の開発にあります。しかし、市場成長は、価格圧力、償還の問題、高い設備投資要件によって妨げられています。注目すべき限界は、認知度やインフラが不十分なため、未開発地域での導入が遅れていることです。新たなビジネスチャンスとしては、組織足場の革新、生物活性創傷ケア製品、バイオテクノロジーの進歩を活用した個別化医療アプローチの開発などが挙げられます。企業は、強化されたバイオマテリアルの研究開発に投資し、研究機関との戦略的提携を活用して技術的進歩を促進することで、こうした展望を生かすことができます。さらに、ヘルスケア支出が増加している新興国での販売網の拡大も、実行可能な成長戦略となり得る。ヘルスケアプロバイダーとのパートナーシップを育み、製品の入手しやすさと値ごろ感を高めることが重要な役割を果たすと思われます。変化する規制への適応力を維持し、持続可能な慣行に注力することで、競合情勢における回復力をさらに確保することができると思われます。結局のところ、市場力学はダイナミックで競争が激しく、イノベーションと規制の俊敏性が持続的な成功のカギとなります。

市場力学：急速に進化するバイオサージェリー市場の主要市場インサイトを公開

バイオサージェリー市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 老人人口の増加と最小侵襲手術の増加
  • 患者における効果的な出血管理のニーズの高まり
  • 政府によるバイオサージェリーへの投資の増加
• 市場抑制要因
  • バイオサージェリーの高コストに関する懸念
• 市場機会
  • 先端技術を駆使したバイオサージェリー製品のイントロダクション
  • 医療ツーリズムの潜在的発展と先端バイオ素材へのニーズの高まり
• 市場の課題
  • 厳しい規制の枠組みと臨床専門家の不足

ポーターの5つの力：バイオサージェリー市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：バイオサージェリー市場における外部からの影響の把握

外部マクロ環境要因は、バイオサージェリー市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析バイオサージェリー市場における競合情勢の把握

バイオサージェリー市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスバイオサージェリー市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、バイオサージェリー市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨バイオサージェリー市場における成功への道筋を描く

バイオサージェリー市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢化人口の増加と低侵襲手術の増加
    • 患者の効果的な失血管理の必要性が高まる
    • 政府によるバイオサージェリーへの投資の増加
  • 抑制要因
    • バイオサージェリーの高コストに関する懸念
  • 機会
    • 先進的でテクノロジー主導のバイオサージェリー製品のイントロダクション
    • 医療ツーリズムの発展の可能性と先端バイオ材料の需要の高まり
  • 課題
    • 厳格な規制枠組みと臨床専門知識の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 バイオサージェリー市場：製品別

• 癒着防止バリア
• 骨移植アタッチメント
• 止血剤
• 軟部組織付着
• 外科用シーラント

第7章 バイオサージェリー市場：ソース別

• 生物製剤
• 合成製品

第8章 バイオサージェリー市場：用途別

• 心臓血管外科
• 一般外科
• 婦人科手術
• 神経外科
• 整形外科
• 胸部外科
• 泌尿器科手術

第9章 バイオサージェリー市場：エンドユーザー別

• クリニック
• 病院

第10章 南北アメリカのバイオサージェリー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のバイオサージェリー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのバイオサージェリー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Aroa Biosurgery Limited
• Artivion, Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson, and Company
• Boston Scientific Corporation
• Cabaletta Bio, Inc.
• CSL Limited
• Getinge AB
• Hemostasis, LLC
• Integra LifeSciences Corporation
• Johnson & Johnson Services Inc.
• Kuros Bioscience AG
• Medtronic PLC
• Ocular Therapeutix, Inc.
• Orthofix Medical, Inc.
• Pfizer Inc.
• RTI Surgical, Inc.
• Samyang Holdings Corporation
• Sanofi SA
• Smith & Nephew plc
• Stryker Corporation
• Tissue Regenix Ltd
• Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. BIOSURGERY MARKET RESEARCH PROCESS
• FIGURE 2. BIOSURGERY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIOSURGERY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BIOSURGERY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOSURGERY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOSURGERY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOSURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOSURGERY MARKET DYNAMICS
• TABLE 7. GLOBAL BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOSURGERY MARKET SIZE, BY ADHESION BARRIERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOSURGERY MARKET SIZE, BY BONE GRAFT ATTACHMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOSURGERY MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOSURGERY MARKET SIZE, BY SOFT TISSUE ATTACHMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOSURGERY MARKET SIZE, BY SURGICAL SEALANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOSURGERY MARKET SIZE, BY BIOLOGICS PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOSURGERY MARKET SIZE, BY SYNTHETIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOSURGERY MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOSURGERY MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOSURGERY MARKET SIZE, BY GYNECOLOGY SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOSURGERY MARKET SIZE, BY NEUROLOGICAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOSURGERY MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOSURGERY MARKET SIZE, BY THORACIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOSURGERY MARKET SIZE, BY UROLOGY SURGERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOSURGERY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOSURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 40. CANADA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. CANADA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. CANADA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES BIOSURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 62. CHINA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. CHINA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 64. CHINA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. CHINA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 66. INDIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. INDIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 68. INDIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. INDIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOSURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 135. ITALY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. ITALY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 137. ITALY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. ITALY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 151. POLAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. POLAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 153. POLAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. POLAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 155. QATAR BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 156. QATAR BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 157. QATAR BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. QATAR BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM BIOSURGERY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 195. BIOSURGERY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 196. BIOSURGERY MARKET, FPNV POSITIONING MATRIX, 2023

The Biosurgery Market was valued at USD 15.13 billion in 2023, expected to reach USD 16.35 billion in 2024, and is projected to grow at a CAGR of 8.17%, to USD 26.22 billion by 2030.

The biosurgery market focuses on the development and application of biologically-originated surgical products, aiding in hemostasis, sealing, and tissue repair. This segment is critical for enhancing surgical outcomes, reducing operative risks, and accelerating recovery. Driven by an aging population, increasing surgical procedures, and technological advancements, the market is poised for growth, yet it faces challenges such as high costs and stringent regulatory scrutiny. Biosurgery finds applications in various surgeries, including orthopedic, cardiovascular, and neurosurgeries, with end-users being hospitals, clinics, and ambulatory surgical centers. Growth is predominantly fueled by an increasing focus on minimally invasive procedures, expansion in emerging markets, and improved healthcare infrastructure globally. Opportunities lie in the development of cost-effective and effective next-generation products, reflecting advances in biocompatible materials and regenerative medicine. However, market growth is hampered by pricing pressures, reimbursement issues, and a high capital investment requirement. A noteworthy limitation is the slow adoption in underdeveloped regions due to inadequate awareness and infrastructure. Emerging opportunities include innovations in tissue scaffolding, bioactive wound care products, and development of personalized medicine approaches leveraging biotechnological advancements. Companies can capitalize on these prospects by investing in R&D for enhanced biomaterials and leveraging strategic collaborations with research institutes to foster technological advancements. Additionally, expanding distribution networks in emerging economies where healthcare expenditure is rising can be a viable growth strategy. Fostering partnerships with healthcare providers to enhance product accessibility and affordability will play a crucial role. Staying adaptive to changing regulations and focusing on sustainable practices may further ensure resilience in a competitive landscape. Ultimately, the biosurgery market's nature is dynamic and highly competitive, with innovation and regulatory agility being keys to sustained success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biosurgery Market

The Biosurgery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising geriatric population and increase in the volume of minimal-invasive surgeries
  • Growing need for effective blood loss management in patients
  • Increase in investments by the government in the biosurgery
• Market Restraints
  • Concern associated with high cost of biosurgery
• Market Opportunities
  • Introduction of advanced and tech-driven biosurgery products
  • Potential development of medical tourism and rise in need for advanced bio materials
• Market Challenges
  • Stringent regulatory framework and dearth of clinical expertise

Porter's Five Forces: A Strategic Tool for Navigating the Biosurgery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biosurgery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biosurgery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biosurgery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biosurgery Market

A detailed market share analysis in the Biosurgery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biosurgery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biosurgery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biosurgery Market

A strategic analysis of the Biosurgery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biosurgery Market, highlighting leading vendors and their innovative profiles. These include Aroa Biosurgery Limited, Artivion, Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson, and Company, Boston Scientific Corporation, Cabaletta Bio, Inc., CSL Limited, Getinge AB, Hemostasis, LLC, Integra LifeSciences Corporation, Johnson & Johnson Services Inc., Kuros Bioscience AG, Medtronic PLC, Ocular Therapeutix, Inc., Orthofix Medical, Inc., Pfizer Inc., RTI Surgical, Inc., Samyang Holdings Corporation, Sanofi SA, Smith & Nephew plc, Stryker Corporation, Tissue Regenix Ltd, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Biosurgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Adhesion Barriers, Bone Graft Attachments, Hemostatic Agents, Soft Tissue Attachments, and Surgical Sealants.
• Based on Source, market is studied across Biologics Products and Synthetic Products.
• Based on Application, market is studied across Cardiovascular Surgery, General Surgery, Gynecology Surgery, Neurological Surgery, Orthopedic Surgery, Thoracic Surgery, and Urology Surgery.
• Based on End-Users, market is studied across Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising geriatric population and increase in the volume of minimal-invasive surgeries
    • 5.1.1.2. Growing need for effective blood loss management in patients
    • 5.1.1.3. Increase in investments by the government in the biosurgery
  • 5.1.2. Restraints
    • 5.1.2.1. Concern associated with high cost of biosurgery
  • 5.1.3. Opportunities
    • 5.1.3.1. Introduction of advanced and tech-driven biosurgery products
    • 5.1.3.2. Potential development of medical tourism and rise in need for advanced bio materials
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory framework and dearth of clinical expertise
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biosurgery Market, by Product

• 6.1. Introduction
• 6.2. Adhesion Barriers
• 6.3. Bone Graft Attachments
• 6.4. Hemostatic Agents
• 6.5. Soft Tissue Attachments
• 6.6. Surgical Sealants

7. Biosurgery Market, by Source

• 7.1. Introduction
• 7.2. Biologics Products
• 7.3. Synthetic Products

8. Biosurgery Market, by Application

• 8.1. Introduction
• 8.2. Cardiovascular Surgery
• 8.3. General Surgery
• 8.4. Gynecology Surgery
• 8.5. Neurological Surgery
• 8.6. Orthopedic Surgery
• 8.7. Thoracic Surgery
• 8.8. Urology Surgery

9. Biosurgery Market, by End-Users

• 9.1. Introduction
• 9.2. Clinics
• 9.3. Hospitals

10. Americas Biosurgery Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biosurgery Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biosurgery Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aroa Biosurgery Limited
• 2. Artivion, Inc.
• 3. B. Braun Melsungen AG
• 4. Baxter International Inc.
• 5. Becton, Dickinson, and Company
• 6. Boston Scientific Corporation
• 7. Cabaletta Bio, Inc.
• 8. CSL Limited
• 9. Getinge AB
• 10. Hemostasis, LLC
• 11. Integra LifeSciences Corporation
• 12. Johnson & Johnson Services Inc.
• 13. Kuros Bioscience AG
• 14. Medtronic PLC
• 15. Ocular Therapeutix, Inc.
• 16. Orthofix Medical, Inc.
• 17. Pfizer Inc.
• 18. RTI Surgical, Inc.
• 19. Samyang Holdings Corporation
• 20. Sanofi SA
• 21. Smith & Nephew plc
• 22. Stryker Corporation
• 23. Tissue Regenix Ltd
• 24. Zimmer Biomet Holdings, Inc.